{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:03:44Z","timestamp":1791147824717,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ymgme.2004.07.003","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T02:13:35Z","timestamp":1093572815000},"page":"163-174","source":"Crossref","is-referenced-by-count":140,"title":["Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I"],"prefix":"10.1016","volume":"83","author":[{"given":"E.","family":"Kakkis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"McEntee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Belichenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Passage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2004.07.003_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2004.07.003_bib2","series-title":"Principles of Child Neurology","first-page":"1141","article-title":"The mucopolysaccharidoses","author":"Kakkis","year":"1996"},{"key":"10.1016\/j.ymgme.2004.07.003_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1469-8749.1973.tb15160.x","article-title":"Cervical cord compression in mucopolysaccharidosis","volume":"15","author":"Kennedy","year":"1973","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2004.07.003_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3171\/jns.1974.41.5.0618","article-title":"Spinal pachymeningitis secondary to mucopolysaccharidosis","volume":"41","author":"Paulson","year":"1974","journal-title":"Case report, J. Neurosurg."},{"key":"10.1016\/j.ymgme.2004.07.003_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1148\/125.2.421","article-title":"Myelographic features of mucopolysaccharidoses: a new sign","volume":"125","author":"Sostrin","year":"1977","journal-title":"Radiology"},{"key":"10.1016\/j.ymgme.2004.07.003_bib6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0090-3019(82)80004-9","article-title":"Cervical myelopathy due to dural compression in mucopolysaccharidosis","volume":"17","author":"Kaufman","year":"1982","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.ymgme.2004.07.003_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00518788","article-title":"Computed tomography studies on patients with mucopolysaccharidoses","volume":"21","author":"Watts","year":"1981","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ymgme.2004.07.003_bib8","first-page":"223","article-title":"Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation","volume":"47","author":"Kachur","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymgme.2004.07.003_bib9","first-page":"251","article-title":"Communicating hydrocephalus in children with genetic inborn errors of metabolism","volume":"1","author":"Fowler","year":"1975","journal-title":"Child\u2019s Brain"},{"key":"10.1016\/j.ymgme.2004.07.003_bib10","first-page":"187","article-title":"Hydrocephalus and shunt placement","volume":"137","author":"Van Aerde","year":"1983","journal-title":"Am. J. Dis. Child"},{"key":"10.1016\/j.ymgme.2004.07.003_bib11","first-page":"556","article-title":"Acute hydrocephalus in Hurler\u2019s syndrome","volume":"136","author":"Shinnar","year":"1982","journal-title":"Am. J. Dis. Child"},{"key":"10.1016\/j.ymgme.2004.07.003_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-3101(24)00309-8","article-title":"Mucopolysaccharidoses","volume":"33","author":"Muenzer","year":"1986","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ymgme.2004.07.003_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler\u2019s disease and biochemical improvement after treatment by bone marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2004.07.003_bib14","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2004.07.003_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/adc.76.2.92","article-title":"Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres","volume":"76","author":"Vellodi","year":"1997","journal-title":"Arch. Dis. Child"},{"key":"10.1016\/j.ymgme.2004.07.003_bib16","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2004.07.003_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320460222","article-title":"Long-term outcome of Hurler syndrome following bone marrow transplantation","volume":"46","author":"Whitley","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2004.07.003_bib18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype","volume":"16","author":"Hopwood","year":"1992","journal-title":"J. Inher. Metab. Dis."},{"key":"10.1016\/j.ymgme.2004.07.003_bib19","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","article-title":"For the European group for bone marrow transplantation, Allogeneic bone marrow transplantation for lysosomal storage diseases","volume":"345","author":"Hoogerbrugge","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2004.07.003_bib20","doi-asserted-by":"crossref","unstructured":"N.W. Barton, R.O. Brady, J.M. Dambrosia, A.M. Di Bisceglie, S.H. Doppelt, S.C. Hill, H.J. G.J. Murray, R.I. Parker, C.E. Argoff, R.P. Grewal, K.-T. Yu, and Colloborators, Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease, N. Engl. J. Med. 324 (2004) 1464\u20131470","DOI":"10.1056\/NEJM199105233242104"},{"key":"10.1016\/j.ymgme.2004.07.003_bib21","doi-asserted-by":"crossref","unstructured":"J.E. Wraith, L.A. Clarke, M. Beck, E.H. Kolodny, G.M. Pastores, J. Muenzer, D.M. Rapoport, K.I. Berger, S.J. Swiedler, E.D. Kakkis, T. Braakman, E. Chadbourne, K. Walton-Bowen, G.F. Cox, Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human \u03b1-l-iduronidase (laronidase), J. Pediatr. 144 (2004) 581\u2013588","DOI":"10.1016\/j.jpeds.2004.01.046"},{"key":"10.1016\/j.ymgme.2004.07.003_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"For the International Collaborative Fabry Disease Study Group, Safety and efficacy of recombinant human \u03b1-galactosidase A replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2004.07.003_bib23","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2004.07.003_bib24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharisosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2004.07.003_bib25","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00006123-199805000-00082","article-title":"Outwitting the blood\u2013brain barrier for therapeutic purposes: osmotic opening and other means","volume":"42","author":"Kroll","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymgme.2004.07.003_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004647-199707000-00001","article-title":"Drug delivery to the brain","volume":"17","author":"Pardridge","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ymgme.2004.07.003_bib27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/mol.57.4.679","article-title":"New advances in the transport of doxorubicin through the blood\u2013brain barrier by a peptide vector-mediated strategy","volume":"57","author":"Rousselle","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymgme.2004.07.003_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1046\/j.1471-4159.2002.01201.x","article-title":"High transcytosis of melanotransferrin (P97) across the blood\u2013brain barrier","volume":"83","author":"Demeule","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2004.07.003_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1022578424693","article-title":"Delivery, distribution, and neuronal uptake of exogenous mannose-terminal glucocerebrosidase in the intact rat brain","volume":"24","author":"Zirzow","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2004.07.003_bib30","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","article-title":"Convection-enhanced delivery of macromolecules in the brain","volume":"91","author":"Bobo","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2004.07.003_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exnr.2000.7571","article-title":"Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotropic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin","volume":"168","author":"Hamilton","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2004.07.003_bib32","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm1297-1362","article-title":"Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors","volume":"3","author":"Laske","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2004.07.003_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/bmme.1996.0044","article-title":"Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I","volume":"58","author":"Kakkis","year":"1996","journal-title":"Biochem. Mol. Med."},{"key":"10.1016\/j.ymgme.2004.07.003_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/prep.1994.1035","article-title":"Overexpression of the human lysosomal enzyme \u03b1-l-iduronidase in Chinese hamster ovary cells","volume":"5","author":"Kakkis","year":"1994","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ymgme.2004.07.003_bib35","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(03)13311-9","article-title":"Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I","volume":"361","author":"Kakavanos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2004.07.003_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.gt.3300364","article-title":"Uptake of \u03b1-(l)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitro","volume":"4","author":"Stewart","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2004.07.003_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0925-4439(02)00166-7","article-title":"Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitro","volume":"1588","author":"Daniele","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2004.07.003_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1014915430398","article-title":"Uptake of mannose-terminal glucocerebrosidase in cultured human cholinergic and dopaminergic neuron cell lines","volume":"27","author":"Schueler","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2004.07.003_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/jgm.377","article-title":"Aspartylglucosaminidase (AGA) is efficiently produced and endocytosed by glial cells: implication for the therapy of a lysosomal storage disorder","volume":"5","author":"Harkke","year":"2003","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymgme.2004.07.003_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1005622001239","article-title":"The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase","volume":"23","author":"Pelled","year":"2000","journal-title":"J. Inher. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719204001763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719204001763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:42:23Z","timestamp":1734522143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719204001763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1096719204001763"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2004.07.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}